PPT: Companion Diagnostics Market to Witness Huge Growth during 2021-2026

1
Global Companion Diagnostics Market Research and
Forecast Report 2021-2026




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Companion Diagnostics Market Research
Report According to the latest report by IMARC
Group, titled "Companion Diagnostics Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2021-2026," the global
companion diagnostics market reached a strong
growth in 2020. Companion diagnostic is an
in-vitro diagnostic testing kit, consisting of a
combination of tests and therapies that are used
for the development of personalized medicines. It
is used to determine the personal molecular
profile of patients that aids healthcare
professionals in deciding upon the approach for
their treatment. It also offers information
regarding the safe and effective use of a certain
corresponding drug or biological product. Its
usage assists in delivering safe and effective
medical care to patients by analyzing the
responders and non-responders to the therapy and
offering an in-depth understanding of the biology
of their disease. Currently, these kits are
widely used in oncology for drug discovery and
delivering targeted therapies to
individuals. Request Free Sample Report
https//www.imarcgroup.com/companion-diagnostics-m
arket/requestsample
4
Report Description and Highlights
Report Description
Global Companion Diagnostics Market Trends The
market is primarily driven by the increasing
incidences of various forms of cancer on the
global level. Companion diagnostics are widely
used in advanced oncology healthcare for
targeting biomarker identification and delivering
targeted therapies to patients, thereby providing
a thrust to the market growth. There has also
been a significant increase in the demand for
in-vitro diagnostics among the masses. This,
along with the growing preference for
personalized healthcare (PHC) and precision
medicine in the healthcare sector, is
facilitating the uptake of these diagnostics.
Apart from this, there has been a rise in the
utilization of targeted drugs and therapies for
treating several infectious, cardiovascular,
neurological, and inflammatory conditions.
Coupled with the development of next-generation
sequencing (NGS) and the increasing number of
clinical trials, this is creating a positive
outlook for the market. Additionally, several
regulatory bodies, such as the US Food and Drug
Administration (US FDA), have provided a defined
structure for companion diagnostic development
while encouraging the market players to conduct
research activities in this field. The continual
launch of new biomarkers, as well as the
increasing number of collaborations between two
or more companies for developing novel companion
diagnostic products, is also providing an impetus
to the market growth. The market is further
driven by the rising application of companion
diagnostics for analyzing the efficacy of
COVID-19 drugs among patients undergoing oncology
therapies. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2021-2026).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Product Service
• Assays, Kits and Reagents
• Software and Services
•  
• Breakup by Technology
• Immunohistochemistry (IHC)
• Polymerase Chain Reaction (PCR)
• In-situ Hybridization (ISH)
• Real-time PCR (RT-PCR)
• Gene Sequencing
• Others 
• Breakup by Indication
• Cancer
• Lung Cancer
• Breast Cancer
• Colorectal Cancer

6
Report Description and Highlights
Report Description

• Neurological Diseases
• Infectious Diseases
• Cardiovascular Diseases
• Others
• Breakup by End User
• Pharmaceutical Biopharmaceutical Companies
• Reference Laboratories
• Contract Research Organizations
• Others
• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India

7
Report Description and Highlights
Report Description

• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Argentina
• Columbia
• Chile
• Peru
• Others

8
Report Description and Highlights
Report Description

• Middle East and Africa Turkey
• Saudi Arabia
• Iran
• United Arab Emirates
• Note We are updating our reports, If you want
  latest primary and secondary data (2021-2026)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.
• Competitive Landscape with Key Players
• Abbott Laboratories
• Agilent Technologies
• BioMerieux
• Danaher Corporation
• Roche Holding AG
• Myriad Genetics Inc.
• Siemens Healthcare
• Thermo Fisher Scientific Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/companion-diagnostics-m
  arket

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us